Nexxen International Ltd. announced a new share‑repurchase program of up to $40 million, to begin once its current program ends. The company also disclosed that it repurchased 412,088 shares in January 2026 at an average price of $6.18, reducing its ordinary shares outstanding to 56,070,588.
The January buyback follows a steady trend of share repurchases: 495,000 shares were bought back in December 2025 at $6.63 each, and 427,500 shares in November 2025 at $7.11. The average price paid in January was lower than in the two preceding months, reflecting a modest decline in the share price and a continued focus on returning capital to shareholders.
The current program, which began in April 2025, was authorized for $50 million and has $5.0 million remaining as of January 31 2026. Nexxen’s new $40 million authorization will allow the company to buy back shares on a discretionary basis, with repurchased shares held as dormant treasury shares under Israeli law. Under that regime, the shares are not counted as outstanding for voting or dividend purposes until they are reissued, providing flexibility for future capital allocation.
Nexxen’s decision to expand its buyback program comes after a strong financial performance in Q1 2025, when Contribution ex‑TAC reached $75.0 million (up 8% YoY) and Adjusted EBITDA rose to $23.1 million (up 95% YoY). The company also reported $164.7 million in cash and cash equivalents as of March 31 2025, giving it ample liquidity to fund the new program while maintaining a healthy balance sheet.
Under Israeli law, dormant treasury shares are held in a separate account and are not considered part of the outstanding share count until they are reissued. This treatment allows Nexxen to keep the shares off the market while preserving the ability to re‑introduce them if needed, thereby protecting shareholder value without diluting current ownership.
The share‑repurchase announcement was well received by the market, with the stock rising 2.49% on the day of the announcement. Analysts noted that the buyback signals management’s confidence in the company’s intrinsic value, especially after a 38% decline in the share price over the previous six months. The new $40 million authorization provides strategic flexibility to capitalize on favorable market conditions without committing to a fixed schedule, reinforcing investor confidence in Nexxen’s capital allocation strategy.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.